Laura Esserman Named 2026 Beacon Award Winner for Women Leaders in Oncology – AIM-HI Accelerator Fund

AIM-HI Accelerator Fund shared on LinkedIn:

“Advancing cancer research takes visionary leaders who challenge convention, drive innovation, and create meaningful change for patients. This year, we are honored to recognize Laura Esserman, as the recipient of the 2026 AIM-HI Beacon Award for Women Leaders in Oncology. An internationally recognized breast cancer surgeon and pioneer in personalized medicine, Dr. Esserman has helped transform approaches to breast cancer research and care.

Join AIM-HI and the National Foundation for Cancer Research (NFCR) on October 9, 2026, at the National Press Club in Washington, DC, as we honor Dr. Esserman at the 2026 AIM-HI Beacon Award Ceremony, held as part of the 2026 NFCR Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship.

Secure your seat and join us.

Read the Full Press Release.”

This also can be interesting:

By Women, for Women: The Untold Stories at the Roots of Oncology